Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and RilpivirineBALAMANE, Maya; VARGHESE, Vici; MELIKIAN, George L et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 8, pp 4522-4524, issn 0066-4804, 3 p.Article

Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitisGANTT, Soren; CARLSSON, Jacquelyn; FRENKEL, Lisa M et al.AIDS (London). 2008, Vol 22, Num 12, pp 1453-1460, issn 0269-9370, 8 p.Article

Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA panelYENI, Patrick G; HAMMER, Scott M; MONTANER, Julio S. G et al.JAMA, the journal of the American Medical Association. 2002, Vol 288, Num 2, pp 222-235, issn 0098-7484Article

Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levelsSIMPSON, David M; HAIDICH, Anna-Bettina; SCHIFITTO, Giovanni et al.AIDS (London). 2002, Vol 16, Num 3, pp 407-412, issn 0269-9370Article

Bayesian network analyses of resistance pathways against efavirenz and nevirapineDEFORCHE, Koen; CAMACHO, Ricardo J; GROSSMAN, Zehave et al.AIDS (London). 2008, Vol 22, Num 16, pp 2107-2115, issn 0269-9370, 9 p.Article

Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assaysSHULMAN, Nancy S; DELGADO, Jamael; BOSCH, Ronald J et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 1, pp 78-81, issn 1525-4135, 4 p.Article

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyTIERNEY, Camlin; LATHEY, Janet L; CHRISTOPHERSON, Cindy et al.The Journal of infectious diseases. 2003, Vol 187, Num 1, pp 144-148, issn 0022-1899, 5 p.Article

Maternal HIV-1 antibody and vertical transmission in subtype C virus infectionGUEVARA, Hugo; CASSEB, Jorge; ZIJENAH, Lynn S et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 29, Num 5, pp 435-440, issn 1525-4135Article

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsBARTLETT, John A; RIBAUDO, Heather J; SUPPARATPINYO, Khuanchai et al.AIDS (London). 2012, Vol 26, Num 11, pp 1345-1353, issn 0269-9370, 9 p.Article

HIV-1 pol mutation frequency by subtype and treatment experience : extension of the HIVseq program to seven non-B subtypesRHEE, Soo-Yon; KANTOR, Rami; KATZENSTEIN, David A et al.AIDS (London). 2006, Vol 20, Num 5, pp 643-651, issn 0269-9370, 9 p.Article

The feasibility of voluntary counselling and HIV testing for pregnant women using community volunteers in ZimbabweSHETTY, Avinash K; MHAZO, Miriam; MOYO, Sostain et al.International journal of STD & AIDS. 2005, Vol 16, Num 11, pp 755-759, issn 0956-4624, 5 p.Article

Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapyLATHEY, Janet L; TIERNEY, Camlin; LANDES, Jeff E et al.The Journal of infectious diseases. 2001, Vol 184, Num 11, pp 1402-1411, issn 0022-1899Article

Characterization of the HIV-1 specific humoral immune response during highly active antiretroviral therapy (HAART)MORRIS, Mary Kate; KATZENSTEIN, David A; ISRAELSKI, Dennis et al.Journal of acquired immune deficiency syndromes (1999). 2001, Vol 28, Num 5, pp 405-415, issn 1525-4135Article

Expanding Antiretroviral Options in Resource-Limited Settings―A Cost-Effectiveness AnalysisBENDAVID, Eran; WOOD, Robin; KATZENSTEIN, David A et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 1, pp 106-113, issn 1525-4135, 8 p.Article

Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milkGANTT, Soren; SHETTY, Avinash K; SEIDEL, Kristy D et al.The Journal of infectious diseases. 2007, Vol 196, Num 4, pp 570-576, issn 0022-1899, 7 p.Article

Genetic correlates of efavirenz hypersusceptibilitySHULMAN, Nancy S; BOSCH, Ronald J; MELLORS, John W et al.AIDS (London). 2004, Vol 18, Num 13, pp 1781-1785, issn 0269-9370, 5 p.Article

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapySHULMAN, Nancy S; MACHEKANO, Roderick A; SHAFER, Robert W et al.Journal of acquired immune deficiency syndromes (1999). 2001, Vol 27, Num 4, pp 377-380, issn 1525-4135Article

Cost-effectiveness of HIV Monitoring Strategies in Resource-Limited Settings : A Southern African AnalysisBENDAVID, Eran; YOUNG, Sean D; KATZENSTEIN, David A et al.Archives of internal medicine (1960). 2008, Vol 168, Num 17, pp 1910-1918, issn 0003-9926, 9 p.Article

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapineLEE, Esther J; KANTOR, Rami; MALDONADO, Yvonne et al.The Journal of infectious diseases. 2005, Vol 192, Num 7, pp 1260-1264, issn 0022-1899, 5 p.Article

Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 yearsZIJENAH, Lynn S; TOBAIWA, Ocean; RUSAKANIKO, Simbarashe et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 4, pp 391-394, issn 1525-4135, 4 p.Article

Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patientsWINTERS, Mark A; BOSCH, Ronald J; ALBRECHT, Mary A et al.The Journal of infectious diseases. 2003, Vol 188, Num 4, pp 537-540, issn 0022-1899, 4 p.Article

Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 monthsSHETTY, Avinash K; COOVADIA, Hoosen M; WELLS, Jennifer et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, Num 5, pp 482-490, issn 1525-4135, 9 p.Article

HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapyKANTOR, Rami; ZIJENAH, Lynn S; SHAFER, Robert W et al.AIDS research and human retroviruses. 2002, Vol 18, Num 18, pp 1407-1413, issn 0889-2229, 7 p.Article

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infectionALBRECHT, Mary A; BOSCH, Ronald J; HAMMER, Scott M et al.The New England journal of medicine. 2001, Vol 345, Num 6, pp 398-407, issn 0028-4793Article

Page / 2